207 related articles for article (PubMed ID: 8066470)
21. [Hematologic masks in liver diseases].
Tentsova IA
Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):43-7. PubMed ID: 6792623
[No Abstract] [Full Text] [Related]
22. Anabolic steroids in muscular, neurologic and hematologic disorders.
Faludi G; Dykyj R; Chayes ZW; Nodine JH
J Am Med Womens Assoc; 1968 Apr; 23(4):346-51. PubMed ID: 4231282
[No Abstract] [Full Text] [Related]
23. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
[TBL] [Abstract][Full Text] [Related]
24. [Long-term treatment of medullary insufficiency with androgens].
Najean Y; Dresh C; Laprevotte I
Minerva Med; 1971 Jun; 62(51):2588-97. PubMed ID: 5566872
[No Abstract] [Full Text] [Related]
25. Androgens in men--uses and abuses.
Bagatell CJ; Bremner WJ
N Engl J Med; 1996 Mar; 334(11):707-14. PubMed ID: 8594431
[No Abstract] [Full Text] [Related]
26. [Late development of chronic pancytopenias, successfully treated with androgens].
Najean Y; Schaison G; Dresch C; Ardaillou N
Nouv Rev Fr Hematol; 1969; 9(1):23-32. PubMed ID: 4237810
[No Abstract] [Full Text] [Related]
27. [Administration of corticosteroids in hematologic diseases].
Haanen C
Ned Tijdschr Geneeskd; 1978 May; 122(19):671-8. PubMed ID: 652084
[No Abstract] [Full Text] [Related]
28. Androgens in anemia.
Roh BL; Wang RI
Wis Med J; 1974 Jul; 73(7):S81-2. PubMed ID: 4847027
[No Abstract] [Full Text] [Related]
29. [Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children].
Wróbel G; Chybicka A; Kazanowska B
Postepy Hig Med Dosw; 2002; 56 Suppl():59-68. PubMed ID: 12661416
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow and blood].
Jamra M; Lorenzi TF
Rev Bras Pesqui Med Biol; 1975; 8(2):149-205. PubMed ID: 1178935
[No Abstract] [Full Text] [Related]
31. The role of lipotropins as hematopoietic factors and their potential therapeutic use.
Halabe Bucay A
Exp Hematol; 2008 Jun; 36(6):752-4. PubMed ID: 18358591
[TBL] [Abstract][Full Text] [Related]
32. [Central immunological cytopenia].
Popa G; Hanganu E
Rev Med Chir Soc Med Nat Iasi; 1981; 85(3):417-21. PubMed ID: 7038809
[No Abstract] [Full Text] [Related]
33. [Immunosuppressive treatment in autoimmunological blood diseases (author's transl)].
Szmigiel Z; Korzeniowska D
Przegl Lek; 1975; 32(12):896-909. PubMed ID: 1219921
[No Abstract] [Full Text] [Related]
34. Rituximab in the treatment of autoimmune haematological disorders.
Provan D; Newland AC; Amadori S; Stasi R
Br J Haematol; 2008 Oct; 143(2):294; author reply 295. PubMed ID: 18752592
[No Abstract] [Full Text] [Related]
35. [Oluprine and hematopoiesis].
Gebauer D
Dtsch Med J; 1971 Oct; 22(19):618-9. PubMed ID: 5130266
[No Abstract] [Full Text] [Related]
36. [High doses of anabolic steroids in the treatment of suppressed bone marrow hematopoiesis].
Steruská M; Hrubisko M
Vnitr Lek; 1976 Feb; 22(2):161-8. PubMed ID: 1258404
[No Abstract] [Full Text] [Related]
37. Progress in the leukemias.
Galton DA; Spiers AS
Prog Hematol; 1971; 7(0):343-405. PubMed ID: 5006109
[No Abstract] [Full Text] [Related]
38. [Androgens and haematopoiesis].
Sébahoun G; Costello R; Rossi D; Tostain J
Prog Urol; 2004 Nov; 14(5):797-800. PubMed ID: 15747628
[No Abstract] [Full Text] [Related]
39. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
[No Abstract] [Full Text] [Related]
40. [Inhibition of hemopoiesis due to cytostatic therapy and its treatment (author's transl)].
Klener P; Donner L; Smotlachová I
Cas Lek Cesk; 1977 Feb; 116(4):117-9. PubMed ID: 844069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
